Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice

Journal of Molecular and Cellular Cardiology

Volumn 32, Issue 1, 2000, Pages 109-120

  Roten, Lisa ^a   Nemoto, Shintaro ^a   Simsic, Janet ^a   Coker, Mytsi L ^a   Rao, Vijay ^a   Baicu, Simona ^a   Defreyte, Gilberto ^a   Soloway, Paul J ^a   Zile, Michael R ^a   Spinale, Francis G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Hypertrophy; Metalloproteinases; Myocardial remodeling; Tissue inhibitor of the metalloproteinases

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GENE DELETION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE;

ANIMALIA;

EID: 0033955876     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1052     Document Type: Article

References (57)

1. Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC, Cruickshank JM, Devereux RB, Giles TD, Korsgaard N, Leier CV, Mendelsohn FAO, Motz WH, Mulvany MJ, Strauer BE. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 20:1992;3-16
2. Factor SM. Role of extracellular matrix in dilated cardiomyopathy. Heart Failure. 9:1994;260-268
3. Janicki, JS, Matsubara, BB, Myocardial collagen and left ventricular diastolic dysfunction, In: Gaash WH, LeWinter MM, Eds. Left Ventricular Diastolic Dysfunction and Heart Failure. Lea and Febiger, New York: 1994; 125-140
4. Borg TK, Burgess ML. Holding it all together: organization and function(s) of the extracellular matrix of the heart. Heart Failure. 8:1993;230-238
5. Robinson TF, Cohen-Gould L, Factor SM. Skeletal framework of mammalian heart muscle. Arrangement of inter- and pericellular connective tissue structures. Lab Invest. 49:1983;482-498
6. Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR. Collagen remodeling and changes in LV function during the development and recovery from supraventricular tachycardia. Am J Physiol. 261:1991;H308-H318
7. Komamura K, Shannon R, Ihara T, Shen Y, Mirsky I, Bishop S, Vatner S. Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol. 265:1993;H1119-H1131
8. Weber KT, Pick R, Janicki JS, Gadodia G, Lakier JB. Inadequate collagen tethers in dilated cardiomyopathy. Am Heart J. 116:1988;1641-1646
9. Gunja-Smith Z, Morales AR, Romanelli R, Woessner JF. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy: role of metalloproteinases and pyridinoline cross links. Am J Pathology. 148:1996;1639-1648
10. Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L. Time dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circulation Research. 82:1998;482-495
11. Spinale FG, Ishihra K, Zile M, DeFryte G, Crawford FA, Carabello BA. The structural basis for changes in left ventricular function and geometry due to chronic mitral regurgitation and following correction of the volume overload. J Thorac Cardiovasc Surg. 106:1993;1147-1157
12. Werb, Z, Alexander, CM, Proteinases and matrix degradation, In: Kelly WN, Harris ED, Ruddy S, Sledge CB, Eds. Textbook of Rheumatology. WB Saunders, New York: 1993; pp. 248-268
13. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathology. 148:1996;1345-1350
14. Hansen-Birkedal H, Moore WGI, Bodden MK, Windsor LJ, Hansen-Birkedal B, DeCarlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 4:1993;197-250
15. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. The FASEB Journal. 5:1991;2145-2154
16. Rees RC, Cottam DW. Regulation of the matrix metalloproteinases: their role in tumor invasion and metastasis (review). Int J Oncology. 2:1993;861-872
17. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ, Spinale FG. Increased matrix metalloÍproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation. 97:1998;1708-1715
18. Li YY, Feldman AM, Sun Y, McTiernan CF. Differential expression of tissue inhibitors of metalloÍproteinases in the failing human heart. Circulation. 98:1998;1728-1734
19. Nagase H. Activational mechanisms of matrix metalloproteinases. Biol Chem. 378:1997;151-160
20. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He C. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloprotease designated TIMP. Proc Natl Acad Sci USA. 86:1989;8207-8211
21. Cawston TE, Curry VA, Clark IM, Hazleman BL. Identification of a new metalloproteinase inhibitor that forms tight-binding complexes with collagenase. Biochem J. 269:1990;183-187
22. Silbiger SM, Jacobson VL, Cupples RL, Koski RA. Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene. 141:1994;293-297
23. Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA, Lim MS. The roles of tissue inhibitors of metalloproteinases in tissue remodeling and cell growth. Int J of Obesity. 20:1996;S9-S15
24. Hammani K, Blakis A, Morsette D, Bowcock AM, Schmutte C, Henriet P, DeClerck YA. Structure and characterization of the human tissue inhibitor of metalloproteinase-2 gene. J Biol Chem. 272:1996;25498-25505
25. Nothnick WB, Soloway PD, Curry TE. Pattern of messenger ribonucleic acid expression of tissue inhibitors of metalloproteinase (TIMPs) during testicular maturation in male mice lacking a functional TIMP-1 gene. Biol Reprod. 59:1998;364-370
26. Nothnick WB, Soloway P, Curry TE. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. Biol Reprod. 56:1997;1181-1188
27. Gardin JM, Siri FM, Kitsis RN, Edwards JG, LeinÍwand LA. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ Research. 76:1995;907-914
28. Hamawaki M, Coffman TM, Lashus A, Koide M, Zile MR, Oliverio MI, DeFryte G, Cooper G, Carabello BA. Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. Am J Physiol. 274:1998;H868-873
29. Hoit B, Ball N, Walsh RA. Invasive hemodynamics and force-frequency relationships in open- versus closed-chested mice. Am J Physiol. 273:1997;H2528-H2533
30. Zile MR, Tanaka R, Lindroth JR, Spinale FG, Carabello BA, Mirsky I. Left ventricular volume determined echocardiography by using a constant LV epicardial long axis to short axis dimension ratio throughout the cardiac cycle. J Am Coll Cardiol. 20:1992;986-983
31. Spinale FG, Zellner JL, Johnson WS, Eble DM, Munyer PA. Cellular and extracellular remodeling with the development and recovery from tachycardia induced cardiomyopathy: changes in fibrillar collagen, myocyte adhesion capacity, and proteoÍglycans. J Mol Cell Cardiol. 28:1996;1591-1608
32. Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial collagen with picosirius red staining and circularly polarized light. Bas Res Cardiol. 89:1994;397-410
33. Kato S, Spinale FG, Tanaka R, Johnson W, Cooper G, Zile MR. Inhibition of collagen cross-linking: effects on fibrillar collagen and left ventricular diastolic function. Am J Physiol. 269:1995;H863-868
34. Colan SD, Borrow KM, Neuman A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load independent index of myocardial contractility. J Am Coll Cardiol. 4:1984;715-724
35. Kass DA, Beyar R, Lankford E et al. Influence of contractile state on curvilinearity of end-systolic pressure-volume relations. Circulation. 79:1989;167-178
36. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis. 18:1976;255-264
37. Olivetti G, Ricci R, Lagrasta C, Maniga E, Sonnenblick EH, Anversa P. Cellular basis of wall remodeling in long-term pressure overload-induced right ventricular hypertrophy in rats. Circ Res. 63:1988;648-657
38. Green J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem. 271:1996;30375-30380
39. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503
40. Tamarina N, McMillan WD, Shively VP, Pearce WH. Expression of matrix metalloproteinases and their inhibitors of aneurysms and normal aorta. Surgery. 122:1997;264-272
41. Brophy CM, Marks WH, Reilly JM, Tilson MD. Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. J Surg Res. 50:1991;653-657
42. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and regulatory dysfunction in disease. Biol Chem. 376:1995;345-355
43. Denhardt DT, Rajan S, Walther SE. Structure-function studies of mouse tissue inhibitor of metalloproteinases-1. Ann NY Acad Sciences. 732:1994;65-74
44. Matsuo T, Carabello BA, Nagatomo Y, Koide M, Hamawaki M, Zile MR, McDermott PJ. Mechanisms of cardiac hypertrophy in canine volume overload. Am J Physiol. 275:1998;H65-H74
45. Grossman W, Jones D, McLaurin LP. Wall stress patterns of hypertrophy in the human left ventricle. J Clin Invest. 56:1975;56-64
46. Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 5:1960;370-382
47. Liu A, Hilbelink DR, Crockett WB, Gerdes AM. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 1. Developing and established hypertrophy. Circ Res. 69:1991;52-58
48. Liu A, Hilbelink DR, Crockett WB, Gerdes AM. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 2. Long-term effects. Circ Res. 69:1991;52-58
49. Onodera T, Tamura T, Said S, McCune SA, Gerdes AM. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension. 32:1998;753-757
50. Robert V, Besse S, Sabri A, Silvestre JS, Assayag P, Van-Thiem N, Swynghedaw B, Delcayre C. Differential regulation of matrix metalloproteinases associated with aging and hypertension in rat heart. Lab Invest. 76:1997;729-738
51. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Nat Acad Sci USA. 86:1989;2632-2636
52. Nagase H, Enghild JJ, Suzuki K, Salvesen G. Stepwise activation mechanisms of the precursor of the matrix metalloproteinase 3 (stromelysin) by proteinases and mercuric acetate. Biochem. 29:1990;5783-5789
53. Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler-Stevenson WG, Seiki M. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT-MMP). FEBS Letters. 385:1996;238-240
54. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature. 370:1994;61-65
55. Gasson JC, Golde DW, Kaupman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary ACC, Grwon EL, Orr EC, Clark SS. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature. 315:1985;768-771
56. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermat. 97:1991;679-685
57. Hayakawa TK, Yamashita K, Tanzawa E, Uchijima E, Iwata K. Growth promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Letters. 298:1992;29-32